| INVESCO EMERGING MARKETS EX-CHINA EQUITY A DIS ANNUAL EUR | RVI ASIA PACÍFICO | 40,30% | 83,96% | 80,01% | · |
| MAPFRE AM - GOOD GOVERNANCE FUND R EUR CAP | RVI GLOBAL | 40,26% | 67,71% | 53,99% | · |
| JPM KOREA EQUITY I2 (ACC) USD | RVI COREA | 40,24% | 115,44% | 77,74% | · |
| FIDELITY FUNDS-EMERGING MARKETS EX CHINA A-ACC-EUR | RVI EMERGENTES | 40,23% | 104,65% | · | · |
| NOMURA FUNDS IRELAND - JAPAN SUSTAINABLE EQUITY CORE FUND A JPY | RVI JAPÓN | 40,22% | 87,33% | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO I SD (CLOSE) EUR CAP | RVI EMERGENTES | 40,19% | 104,76% | · | · |
| SCHRODER ISF EMERGING MARKETS EX CHINA E ACC USD | RVI EMERGENTES | 40,18% | · | · | · |
| SCHRODER ISF EMERGING MARKETS EX CHINA IZ ACC USD | RVI EMERGENTES | 40,17% | · | · | · |
| DIP - PARADIGMA VALUE CATALYST EQUITY A EUR CAP | RVI GLOBAL | 40,12% | 78,32% | 106,10% | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO I SD (CLOSE) GBP CAP | RVI EMERGENTES | 40,10% | 104,36% | · | · |
| TELESCOPE BIOTECH FUND, FIL ASESOR | MIXTO FLEXIBLE | 39,97% | · | · | · |
| INVESCO NASDAQ BIOTECH UCITS ETF ACC | RVI BIOTECNOLOGÍA | 39,96% | 93,68% | 60,74% | 147,77% |
| L&G HEALTHCARE BREAKTHROUGH UCITS ETF USD ACC ETF | RVI BIOTECNOLOGÍA | 39,92% | 92,29% | · | · |
| ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF USD (ACC) | RVI BIOTECNOLOGÍA | 39,91% | 93,53% | 60,60% | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO I (CLOSE) EUR CAP | RVI EMERGENTES | 39,90% | 103,34% | · | · |
| INVESCO S&P WORLD ENERGY ESG UCITS ETF ACC | RVI ENERGÍA | 39,89% | 51,10% | · | · |
| BGF WORLD ENERGY A2 HKD (HEDGED) | RVI ENERGÍA | 39,86% | 43,36% | 108,57% | 92,97% |
| DWS INVEST CROCI US DIVIDENDS USD IC50 | RVI USA | 39,85% | 63,56% | 76,67% | · |
| JPM KOREA EQUITY I (ACC) USD | RVI COREA | 39,84% | 113,89% | 75,94% | 243,60% |
| SCHRODER ISF EMERGING MARKETS EX CHINA C ACC USD | RVI EMERGENTES | 39,84% | · | · | · |
